AU2000260652B2 - Extended type 1 chain glycosphingolipids as tumor-associated antigens - Google Patents
Extended type 1 chain glycosphingolipids as tumor-associated antigens Download PDFInfo
- Publication number
- AU2000260652B2 AU2000260652B2 AU2000260652A AU2000260652A AU2000260652B2 AU 2000260652 B2 AU2000260652 B2 AU 2000260652B2 AU 2000260652 A AU2000260652 A AU 2000260652A AU 2000260652 A AU2000260652 A AU 2000260652A AU 2000260652 B2 AU2000260652 B2 AU 2000260652B2
- Authority
- AU
- Australia
- Prior art keywords
- neuaca2
- fucal
- isolated compound
- 4glc
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Crystallography & Structural Chemistry (AREA)
- Polymers & Plastics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2000/018219 WO2002002127A1 (en) | 2000-07-03 | 2000-07-03 | Extended type 1 chain glycosphingolipids as tumor-associated antigens |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2000260652A1 AU2000260652A1 (en) | 2002-04-11 |
| AU2000260652B2 true AU2000260652B2 (en) | 2005-10-27 |
Family
ID=21741553
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2000260652A Expired AU2000260652B2 (en) | 2000-07-03 | 2000-07-03 | Extended type 1 chain glycosphingolipids as tumor-associated antigens |
| AU6065200A Pending AU6065200A (en) | 2000-07-03 | 2000-07-03 | Extended type 1 chain glycosphingolipids as tumor-associated antigens |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU6065200A Pending AU6065200A (en) | 2000-07-03 | 2000-07-03 | Extended type 1 chain glycosphingolipids as tumor-associated antigens |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1307207A4 (enExample) |
| JP (1) | JP2004502025A (enExample) |
| KR (1) | KR100666238B1 (enExample) |
| CN (1) | CN1291723C (enExample) |
| AU (2) | AU2000260652B2 (enExample) |
| WO (1) | WO2002002127A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5331293B2 (ja) * | 2006-04-28 | 2013-10-30 | 公益財団法人野口研究所 | 多様性を表現するオリゴ糖またはその誘導体 |
| KR101432474B1 (ko) * | 2008-09-07 | 2014-08-21 | 글라이코넥스 인코포레이티드 | 항-연장된 ⅰ형 글라이코스핑고지질 항체, 이의 유도체 및 용도 |
| CN104655859B (zh) * | 2013-11-21 | 2017-10-03 | 苏州中赢医疗科技有限公司 | 乳腺癌的诊断标志物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6083929A (en) * | 1991-05-06 | 2000-07-04 | The Biomembrane Institute | Extended type 1 chain glycosphingolipids as tumor-associated antigens |
| WO1992019634A1 (en) * | 1991-05-06 | 1992-11-12 | The Biomembrane Institute | Extended type 1 chain glycosphingolipids as tumor-associated antigens |
-
2000
- 2000-07-03 WO PCT/US2000/018219 patent/WO2002002127A1/en not_active Ceased
- 2000-07-03 CN CNB008197881A patent/CN1291723C/zh not_active Expired - Lifetime
- 2000-07-03 JP JP2002506748A patent/JP2004502025A/ja active Pending
- 2000-07-03 AU AU2000260652A patent/AU2000260652B2/en not_active Expired
- 2000-07-03 KR KR1020037000034A patent/KR100666238B1/ko not_active Expired - Lifetime
- 2000-07-03 AU AU6065200A patent/AU6065200A/xx active Pending
- 2000-07-03 EP EP00946971A patent/EP1307207A4/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004502025A (ja) | 2004-01-22 |
| CN1291723C (zh) | 2006-12-27 |
| EP1307207A1 (en) | 2003-05-07 |
| CN1460022A (zh) | 2003-12-03 |
| KR20030068120A (ko) | 2003-08-19 |
| WO2002002127A1 (en) | 2002-01-10 |
| EP1307207A4 (en) | 2005-12-14 |
| AU6065200A (en) | 2002-01-14 |
| KR100666238B1 (ko) | 2007-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Le Pendu et al. | ABH and Lewis histo‐blood group antigens in cancer | |
| Stroud et al. | Extended type 1 chain glycosphingolipids: dimeric Lea (III4V4Fuc2Lc6) as human tumor-associated antigen | |
| Satoh et al. | Enhanced GM3 expression, associated with decreased invasiveness, is induced by brefeldin A in bladder cancer cells | |
| US20030133937A1 (en) | Methods and compositions for the inhibition of cancer metastasis mediated by endothelial adhesion molecules | |
| Casadesús et al. | A shift from N-glycolyl-to N-acetyl-sialic acid in the GM3 ganglioside impairs tumor development in mouse lymphocytic leukemia cells | |
| Goletz et al. | Thomsen-Friedenreich antigen: the “hidden” tumor antigen | |
| Mårtensson et al. | A carbohydrate epitope associated with human squamous lung cancer | |
| US6083929A (en) | Extended type 1 chain glycosphingolipids as tumor-associated antigens | |
| EP2113515A2 (en) | GalNAc specific binding molecules and uses thereof | |
| AU2000260652B2 (en) | Extended type 1 chain glycosphingolipids as tumor-associated antigens | |
| Masson et al. | Cancer-associated tumour markers CA 19-9 and CA-50 in patients with pancreatic cancer with special reference to the Lewis blood cell status | |
| Ito et al. | Specificity and immunobiological properties of monoclonal antibody IMH2, established after immunization with Leb/Lea glycosphingolipid, a novel extended type 1 chain antigen | |
| JPH07504222A (ja) | 化学的に規定されるオリゴ糖,該オリゴ糖の誘導体,擬態物及び該オリゴ糖に対する抗体による細胞接着の抑制 | |
| AU2000260652A1 (en) | Extended type 1 chain glycosphingolipids as tumor-associated antigens | |
| EP1169044B1 (en) | Use of fucosylated sialylated n-acetyl lactosamine carbohydrate structures for inhibition of bacterial adherence | |
| Medina et al. | Human colon adenocarcinomas express a MUC1-associated novel carbohydrate epitope on core mucin glycans defined by a monoclonal antibody (A10) raised against murine Ehrlich tumor cells | |
| Garratty | Do blood groups have a biological role | |
| AU659808B2 (en) | Inhibition of metastasis potential and invasiveness by oligosaccharides or oligosaccharide antigens or antibodies | |
| WO1992019634A1 (en) | Extended type 1 chain glycosphingolipids as tumor-associated antigens | |
| Hiraiwa et al. | Monoclonal antibodies directed to a disulfated glycosphingolipid, SB1a (GgOse4Cer-II3IV3-bis-sulfate), associated with human hepatocellular carcinoma | |
| FUKUSHIMA | Expression of Lewisx, sialylated Lewisx, Lewisa, and sialylated Lewisa antigens in human lung carcinoma | |
| JP2007191490A (ja) | 腫瘍関連抗原としての拡張i型スフィンゴ糖脂質鎖 | |
| Okada et al. | Hepatocellular expression of a novel glycoprotein with sialylated difucosyl Lex activity in the active inflammatory lesions of chronic liver disease | |
| Hanisch et al. | Monoclonal antibody FW6 defines an epitope on α3/4-monofucosylated polylactosaminoglycans expressed by fetal and colon carcinoma-associated mucins | |
| Laferté et al. | Monoclonal antibody recognizing a determinant on type 2 chain blood group A and B oligosaccharides detects oncodevelopmental changes in azoxymethane‐induced rat colon tumors and human colon cancer cell lines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |